Skip to content

Development and Initial Validation of an Early Pulmonary Rehabilitation Program for Severe Pneumonia Patients Assisted by Nursing Ultrasound

Development and Initial Validation of an Early Pulmonary Rehabilitation Program for Severe Pneumonia Patients Assisted by Nursing Ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129006
Enrollment
Unknown
Registered
2026-07-29
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Ultrasound group:Early pulmonary rehabilitation program for critically ill pneumonia patients assisted by nursing ultrasound
Conventional group:Early pulmonary rehabilitation for patients with severe pneumonia under routine assessment

Sponsors

The affiliated hospital of southwest medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Adult patients diagnosed with severe pneumonia according to the criteria in "Internal Medicine" (10th edition); 2. Age is between 18 and 80 years old (inclusive); 3. The patient himself/herself or their legal representative has given informed consent and voluntarily participated in the study; 4. Can be used in conjunction with the completion of ultrasound dynamic assessment (at least once per day); 5. Patients without tracheal intubation.

Exclusion criteria

Exclusion criteria: 1.Patients with severe mental disorders, confusion of consciousness, delirium, coma, or pregnant or lactating women; 2.There are contraindications for lung ultrasound examination (such as severe chest trauma, extensive subcutaneous emphysema, allergy to ultrasound coupling agent, etc.); 3.Patients with advanced secondary pulmonary heart disease: According to the researchers' assessment, there are severe comorbidities that affect the outcome indicators (such as those with concurrent pulmonary tuberculosis, lung tumors, pulmonary fibrosis or other lung diseases, or severe immunodeficiency, etc.); 4.Patients who are also participating in other clinical studies; 5.The estimated hospital stay is less than 7 days.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;

Secondary

MeasureTime frame
Diaphragmatic mobility;The occurrence of complications;Lung ultrasound score;hospital stays;Diaphragm thickening rate;

Countries

China

Contacts

Public ContactHu Xiaojing

The affiliated hospital of southwest medical university

334387072@qq.com+86 830 3165487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026